Who invested in Endogenex?
Endogenex's investors include Arboretum Ventures, Hatteras Venture Partners, Mayo Clinic, Longitude Capital and Lumira Ventures, and 3 more on record. Arboretum Ventures led its latest round.

United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$138Mraised across 2 rounds since 2024, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by Hatteras Venture PartnersSEC filing: $70M sold, first sale Jun 2024
From Endogenex's own website and the SEC filings it signed: 6 on the team.
On the board, as filediGerald BrunkJeffrey Terrell
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Endogenex's investors include Arboretum Ventures, Hatteras Venture Partners, Mayo Clinic, Longitude Capital and Lumira Ventures, and 3 more on record. Arboretum Ventures led its latest round.
Endogenex has raised $138M across 2 rounds since 2024.
Endogenex's most recent round was a Series C of $50M in Mar 2026, led by Arboretum Ventures.
Endogenex's largest round on record is $88M (Series C), in Jun 2024.
Endogenex's first round on record, in Jun 2024, was backed by Hatteras Venture Partners, Mayo Clinic and Longitude Capital and 4 others.
Endogenex's latest named round is a Series C, in Mar 2026.
Endogenex is based in the United States.
Arboretum Ventures led the Series C in 2026.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.